# OnCo record nodal-marginal-zone-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/nodal-marginal-zone-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "nodal-marginal-zone-lymphoma" ;
  schema:name "Nodal marginal zone lymphoma"@en ;
  schema:alternateName "NMZL"@en, "Nodal marginal zone B cell lymphoma"@en, "Nodal marginal zone B-cell lymphoma"@en, "Monocytoid B-cell lymphoma"@en, "Paediatric nodal marginal zone lymphoma"@en ;
  schema:description "Nodal marginal zone lymphoma is a slow-growing lymphoma of the lymph nodes that looks like the MALT and splenic types under the microscope but has no organ or spleen involvement to explain it. It lacks a diagnostic marker, so it is diagnosed by excluding the other small B-cell lymphomas, and it is treated like follicular lymphoma with rituximab-based therapy."@en ;
  schema:url <https://onco.cc/cancers/nodal-marginal-zone-lymphoma/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Marginal_zone_B-cell_lymphoma> ;
  schema:citation <https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq>, <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1016/j.annonc.2019.10.010>, <https://doi.org/10.1182/blood-2016-02-696757>, <https://doi.org/10.1182/blood-2011-02-339556> ;
  onco:tag "subtype-page", "wave4", "haematologic", "rare" ;
  onco:related <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/malt-lymphoma/>, <https://onco.cc/cancers/splenic-marginal-zone-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/bendamustine/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/zanubrutinib/> ;
  onco:trials <https://onco.cc/trials/augment/>, <https://onco.cc/trials/fort/> ;
  onco:standardOfCare <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/bendamustine/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/zanubrutinib/> .